Perioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience

scientific article published on 07 September 2018

Perioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSPROCEED.2018.08.034
P698PubMed publication ID30577251

P2093author name stringJ Kim
S H Hong
Y Kim
H J Choi
H S Chung
J H Choi
J Y Jung
C S Park
J Huh
M S Chae
Y R Ko
P2860cites workPosttransplant sarcopenia: an underrecognized early consequence of liver transplantationQ26996234
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cellsQ31833462
Sarcopenia and mortality after liver transplantation.Q34037794
Live donor liver transplantation in adultsQ34569486
Mechanisms of muscle wasting in chronic kidney diseaseQ34723810
PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantationQ36059764
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With CirrhosisQ36752026
Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantationQ37408216
Objective measures of health-related quality of life over 24 months post-liver transplantationQ38475494
Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive AgentsQ38872876
Understanding Age-Related Changes in Skeletal Muscle Metabolism: Differences Between Females and MalesQ38901484
Predictive Role of Intraoperative Plasma Fibrinogen for Postoperative Portal Venous Flow in Living Donor Liver TransplantationQ38963221
Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.Q43660500
A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantationQ43694909
Trends in organ donation and transplantation in the United States, 1999-2008.Q44125408
Liver transplantation: past, present and futureQ44195675
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expressionQ44422727
Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration.Q46573496
Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysisQ47104014
ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.Q47825124
Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.Q48173320
Risk factors for loss of lean body mass after liver transplantation.Q52867211
A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation.Q52931158
Impact of sarcopenia on survival in patients undergoing living donor liver transplantation.Q53110843
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humansQ57221649
Muscle Wasting Is Associated With Mortality in Patients With CirrhosisQ57314875
Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in ratsQ72205059
Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgeryQ74372917
Factors associated with nutritional status in liver transplant patients who survived the first year after transplantationQ94946506
P433issue10
P304page(s)3656-3660
P577publication date2018-09-07
P1433published inTransplantation ProceedingsQ7834825
P1476titlePerioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience
P478volume50

Search more.